← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

ESTA logoEstablishment Labs Holdings Inc.(ESTA)Earnings, Financials & Key Ratios

ESTA•NASDAQ
$74.68
$2.19B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryAesthetics, dermatology, and wound care
AboutEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Show more
  • Revenue$211M+27.1%
  • EBITDA-$33M+22.7%
  • Net Income-$51M+39.6%
  • EPS (Diluted)-1.72+42.7%
  • Gross Margin69.32%+5.1%
  • EBITDA Margin-15.52%+39.2%
  • Operating Margin-18.48%+38.6%
  • Net Margin-24.19%+52.5%
  • ROE-133.25%+43.7%
  • ROIC-14.61%+30.1%
  • Debt/Equity11.23+164.7%
  • Interest Coverage-1.30+57.6%
Technical→

ESTA Key Insights

Establishment Labs Holdings Inc. (ESTA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 20.0%

✗Weaknesses

  • ✗High debt to equity ratio of 11.2x
  • ✗Negative free cash flow
  • ✗Expensive at 93.9x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ESTA Price & Volume

Establishment Labs Holdings Inc. (ESTA) stock price & volume — 10-year historical chart

Loading chart...

ESTA Growth Metrics

Establishment Labs Holdings Inc. (ESTA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years20.04%
3 Years9.29%
TTM27.14%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM39.64%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM42.2%

Return on Capital

10 Years-48.25%
5 Years-23.57%
3 Years-22.8%
Last Year-14.09%

ESTA Recent Earnings

Establishment Labs Holdings Inc. (ESTA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026
EPS
$0.45
Est $0.35
-26.8%
Revenue
$60M
Est $57M
+4.3%
Q1 2026
Feb 24, 2026
EPS
$0.09
Est $0.21
+58.1%
Revenue
$65M
Est $64M
+1.3%
Q4 2025
Nov 5, 2025
EPS
$0.38
Est $0.54
+29.6%
Revenue
$54M
Est $64M
-15.7%
Q3 2025
Aug 7, 2025
EPS
$0.57
Est $0.54
-5.6%
Revenue
$51M
Est $52M
-2.2%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.45vs $0.35-26.8%
$60Mvs $57M+4.3%
Q1 2026Feb 24, 2026
$0.09vs $0.21+58.1%
$65Mvs $64M+1.3%
Q4 2025Nov 5, 2025
$0.38vs $0.54+29.6%
$54Mvs $64M-15.7%
Q3 2025Aug 7, 2025
$0.57vs $0.54-5.6%
$51Mvs $52M-2.2%
Based on last 12 quarters of dataView full earnings history →

ESTA Peer Comparison

Establishment Labs Holdings Inc. (ESTA) competitors in Aesthetics, dermatology, and wound care — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ALGN logoALGNAlign Technology, Inc.Direct Competitor12.46B173.9430.790.9%10.5%10.7%0.03
INMD logoINMDInMode Ltd.Direct Competitor861.05M13.599.50-6.16%25.33%14.52%0.02
AEYE logoAEYEAudioEye, Inc.Direct Competitor95.09M7.66-30.6414.52%-7.63%-47.8%0.15
ATEC logoATECAlphatec Holdings, Inc.Product Competitor1.06B6.99-7.2824.95%-21.07%-141.88%17.21
NVCR logoNVCRNovoCure LimitedProduct Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85
XTNT logoXTNTXtant Medical Holdings, Inc.Product Competitor80.8M0.58-4.8128.44%1.32%3.77%0.82
SYK logoSYKStryker CorporationSupply Chain111.96B292.3334.8011.16%12.92%15.04%0.66
ZBH logoZBHZimmer Biomet Holdings, Inc.Supply Chain16.22B82.8323.337.2%9.05%5.77%0.59

Compare ESTA vs Peers

Establishment Labs Holdings Inc. (ESTA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ALGN

Most directly comparable listed peer for ESTA.

Scale Benchmark

vs ABT

Larger-name benchmark to compare ESTA against a more recognizable public peer.

Peer Set

Compare Top 5

vs ALGN, INMD, AEYE, ATEC

ESTA Income Statement

Establishment Labs Holdings Inc. (ESTA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue34.68M61.21M89.56M84.68M126.68M161.7M165.15M166.03M211.08M
Revenue Growth %75.15%76.49%46.33%-5.46%49.61%27.64%2.13%0.53%27.14%
Cost of Goods Sold16.98M25.09M34.7M32.17M41.28M55.1M58.17M56.5M64.77M
COGS % of Revenue48.96%40.99%38.75%38%32.58%34.08%35.22%34.03%30.68%
Gross Profit
17.7M▲ 0%
36.12M▲ 104.0%
54.86M▲ 51.9%
52.5M▼ 4.3%
85.4M▲ 62.7%
106.59M▲ 24.8%
106.98M▲ 0.4%
109.53M▲ 2.4%
146.31M▲ 33.6%
Gross Margin %51.04%59.01%61.25%62%67.42%65.92%64.78%65.97%69.32%
Gross Profit Growth %75.34%104.03%51.89%-4.3%62.67%24.81%0.36%2.38%33.58%
Operating Expenses37.69M59.98M85.8M80.42M110.54M146.25M172M159.51M185.32M
OpEx % of Revenue108.66%98%95.8%94.97%87.26%90.45%104.15%96.08%87.8%
Selling, General & Admin30.82M47.3M70.81M66.63M92.23M125.98M145.57M139.81M165.07M
SG&A % of Revenue88.87%77.27%79.06%78.68%72.8%77.91%88.15%84.21%78.2%
Research & Development6.86M12.69M14.99M13.79M18.32M20.27M26.43M19.71M20.25M
R&D % of Revenue19.79%20.73%16.74%16.29%14.46%12.53%16%11.87%9.59%
Other Operating Expenses000000000
Operating Income
-19.98M▲ 0%
-23.86M▼ 19.4%
-30.94M▼ 29.7%
-27.92M▲ 9.8%
-25.14M▲ 9.9%
-39.66M▼ 57.7%
-65.03M▼ 64.0%
-49.99M▲ 23.1%
-39.01M▲ 22.0%
Operating Margin %-57.62%-38.99%-34.55%-32.97%-19.84%-24.53%-39.37%-30.11%-18.48%
Operating Income Growth %-26.21%-19.42%-29.66%9.78%9.94%-57.75%-63.97%23.13%21.96%
EBITDA-18.04M-21.06M-27.64M-24.25M-21.03M-35.49M-60.14M-42.41M-32.77M
EBITDA Margin %-52.03%-34.41%-30.86%-28.64%-16.6%-21.95%-36.42%-25.54%-15.52%
EBITDA Growth %-18.39%-16.74%-31.22%12.26%13.27%-68.72%-69.47%29.48%22.74%
D&A (Non-Cash Add-back)1.94M2.8M3.3M3.66M4.11M4.17M4.88M7.58M0
EBIT-24.37M-12.07M-28.81M-28.64M-30.65M-61.06M-63.19M-63.8M-32.77M
Net Interest Income-10.4M-8.8M-8.69M-9.36M-9.04M-11.67M-14.37M-19.35M-24.83M
Interest Income19K16K4K15K23K87K1.02M1.48M423K
Interest Expense10.42M8.81M8.7M9.37M9.06M11.76M15.39M20.83M25.26M
Other Income/Expense-14.81M2.98M-6.57M-10.1M-14.57M-33.17M-13.56M-34.64M-19.01M
Pretax Income
-34.79M▲ 0%
-20.88M▲ 40.0%
-37.51M▼ 79.6%
-38.02M▼ 1.4%
-39.71M▼ 4.5%
-72.82M▼ 83.4%
-78.58M▼ 7.9%
-84.63M▼ 7.7%
-58.02M▲ 31.4%
Pretax Margin %-100.32%-34.12%-41.88%-44.9%-31.35%-45.04%-47.58%-50.97%-27.49%
Income Tax105K215K640K104K1.43M2.38M-81K-32K-6.96M
Effective Tax Rate %-0.3%-1.03%-1.71%-0.27%-3.59%-3.28%0.1%0.04%11.99%
Net Income
-34.9M▲ 0%
-21.1M▲ 39.5%
-38.15M▼ 80.8%
-38.12M▲ 0.1%
-41.14M▼ 7.9%
-75.21M▼ 82.8%
-78.5M▼ 4.4%
-84.6M▼ 7.8%
-51.06M▲ 39.6%
Net Margin %-100.62%-34.47%-42.59%-45.02%-32.47%-46.51%-47.53%-50.95%-24.19%
Net Income Growth %-57.48%39.54%-80.82%0.08%-7.92%-82.82%-4.38%-7.76%39.64%
Net Income (Continuing)-34.9M-21.1M-38.15M-38.12M-41.14M-75.21M-78.5M-84.6M-51.06M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)
-1.89▲ 0%
-1.22▲ 35.4%
-1.86▼ 52.5%
-1.63▲ 12.4%
-1.72▼ 5.5%
-3.08▼ 79.1%
-3.07▲ 0.3%
-3.00▲ 2.3%
-1.72▲ 42.7%
EPS Growth %-57.5%35.45%-52.46%12.37%-5.52%-79.07%0.32%2.28%42.67%
EPS (Basic)-2.33-1.22-1.86-1.63-1.72-3.08-3.07-3.00-1.72
Diluted Shares Outstanding18.49M17.35M20.54M23.32M23.97M24.46M25.6M28.16M29.62M
Basic Shares Outstanding14.98M17.35M20.54M23.32M23.97M24.46M25.6M28.16M29.62M
Dividend Payout Ratio---------

ESTA Balance Sheet

Establishment Labs Holdings Inc. (ESTA) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets39.38M99.44M95.84M132.3M113.27M149.9M174.9M243.04M249.94M
Cash & Short-Term Investments10.86M52.64M37.66M84.52M53.41M66.36M40.03M90.35M75.57M
Cash Only10.86M52.64M37.66M84.52M53.41M66.36M40.03M90.35M75.57M
Short-Term Investments000000000
Accounts Receivable13.11M17.65M22.77M19.13M24.44M35.42M46.92M65M77.5M
Days Sales Outstanding137.96105.2492.7882.4570.4179.96103.69142.9134.01
Inventory13.17M24.84M28.66M23.21M28.41M36.58M79.47M78.77M85.61M
Days Inventory Outstanding283.18361.44301.43263.31251.19242.32498.62508.84482.46
Other Current Assets04.3M1.27M2.09M1.77M1.57M2.42M2.61M11.26M
Total Non-Current Assets17.71M17.14M20.69M24.09M26.26M61.16M93.74M103.79M107.23M
Property, Plant & Equipment13.5M12.91M16.42M18.81M20.86M54.79M80.59M83.59M79.95M
Fixed Asset Turnover2.57x4.74x5.46x4.50x6.07x2.95x2.05x1.99x2.64x
Goodwill465K465K465K465K465K465K465K1.21M1.21M
Intangible Assets3.4M3.44M3.44M4.15M4.37M4.61M7.99M11.68M9.94M
Long-Term Investments75K00000000
Other Non-Current Assets347K315K368K664K558K1.29M4.7M7.31M16.12M
Total Assets
57.09M▲ 0%
116.57M▲ 104.2%
116.53M▼ 0.0%
156.39M▲ 34.2%
139.53M▼ 10.8%
211.06M▲ 51.3%
268.64M▲ 27.3%
346.83M▲ 29.1%
357.17M▲ 3.0%
Asset Turnover0.61x0.53x0.77x0.54x0.91x0.77x0.61x0.48x0.59x
Asset Growth %93.14%104.17%-0.04%34.2%-10.78%51.27%27.28%29.11%2.98%
Total Current Liabilities57.44M16.45M23.24M25.9M31.89M38.96M57.15M68.28M82.14M
Accounts Payable9.13M6.24M10.37M9.72M14.47M20.03M41.62M44.76M43.11M
Days Payables Outstanding196.2990.76109.02110.29127.99132.7261.16289.16242.94
Short-Term Debt24.09M000000012.41M
Deferred Revenue (Current)2.33M908K785K1.21M769K1.69M1.84M1.75M0
Other Current Liabilities21.89M4.12M7.53M8.63M9.08M9.88M4.57M5.53M24.91M
Current Ratio0.69x6.05x4.12x5.11x3.55x3.85x3.06x3.56x3.04x
Quick Ratio0.46x4.54x2.89x4.21x2.66x2.91x1.67x2.41x2.00x
Cash Conversion Cycle224.85375.91285.19235.46193.6189.58341.16362.59373.53
Total Non-Current Liabilities4.67M30.64M53.67M55.53M56.9M180.29M193.1M225.46M251.48M
Long-Term Debt022.32M48.14M49.83M51.91M175.46M188.74M219.58M247.52M
Capital Lease Obligations599K001.92M1.9M3.2M2.71M4.2M2.82M
Deferred Tax Liabilities03.58M0000000
Other Non-Current Liabilities4.07M7.13M4.19M1.91M703K-44K147K554K0
Total Liabilities62.11M47.09M76.92M81.43M88.79M219.25M250.25M293.74M333.62M
Total Debt24.09M22.32M48.4M52.54M54.21M179.35M192.22M225.29M264.47M
Net Debt13.22M-30.32M10.74M-31.98M793K112.99M152.19M134.95M188.9M
Debt / Equity-0.32x1.22x0.70x1.07x-10.45x4.24x11.23x
Debt / EBITDA---------
Net Debt / EBITDA---------
Interest Coverage-2.34x-1.37x-3.31x-3.06x-3.38x-5.19x-4.11x-3.06x-1.30x
Total Equity
-5.01M▲ 0%
69.48M▲ 1486.1%
39.61M▼ 43.0%
74.96M▲ 89.2%
50.74M▼ 32.3%
-8.19M▼ 116.1%
18.39M▲ 324.7%
53.09M▲ 188.6%
23.55M▼ 55.7%
Equity Growth %81.04%1486.1%-42.99%89.23%-32.31%-116.13%324.74%188.64%-55.65%
Book Value per Share-0.274.001.933.212.12-0.330.721.890.79
Total Shareholders' Equity-5.01M69.48M39.61M74.96M50.74M-8.19M18.39M53.09M23.55M
Common Stock41.27M145.71M147.69M213.47M219.74M223.64M315.63M420.36M433.38M
Retained Earnings-67.88M-88.97M-127.13M-165.25M-206.38M-281.59M-360.1M-444.69M-495.76M
Treasury Stock-6.46M-2.85M-2.85M-2.85M-2.85M-2.85M-2.85M-2.85M-2.85M
Accumulated OCI76K449K691K2.87M3.66M2.71M1.96M3.29M1.16M
Minority Interest000000000

ESTA Cash Flow Statement

Establishment Labs Holdings Inc. (ESTA) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-31.97M-33.88M-29.98M-12.51M-27.53M-52.17M-88.51M-58.52M-50.89M
Operating CF Margin %-92.18%-55.36%-33.48%-14.77%-21.73%-32.26%-53.6%-35.25%-24.11%
Operating CF Growth %-124.1%-5.99%11.52%58.28%-120.08%-89.47%-69.68%33.89%13.03%
Net Income-34.9M-21.1M-38.15M-38.12M-41.14M-75.21M-78.5M-84.6M-51.06M
Depreciation & Amortization1.94M2.81M3.29M3.71M4.12M4.34M4.88M7.58M-9.56M
Stock-Based Compensation3.3M7.32M6.53M5.72M10.41M13.36M14.86M15.37M-11.41M
Deferred Taxes4.96M-13.94M02.48M7K86K-3.71M-2.18M6.96M
Other Non-Cash Items7.05M5.04M2.95M1.39M5.51M26.8M8.08M20.81M27.36M
Working Capital Changes-14.32M-14.02M-4.6M12.31M-6.44M-21.54M-34.13M-15.5M-13.17M
Change in Receivables-6.91M-4.67M-5.51M3.81M-6.7M-12.33M-11.56M-26.28M-11.47M
Change in Inventory-6.44M-6.98M-3.37M4.79M-7.64M-10.9M-42.23M-471K-7.06M
Change in Payables-878K-3.9M1.83M-910K4.96M4.38M18.96M6.67M-2.3M
Cash from Investing-845K-5.73M-7.77M-5.56M-7.16M-34.79M-24.55M-15.61M-7.03M
Capital Expenditures-941K-1.77M-6.29M-3.91M-6.73M-34.27M-7.91M-6.11M0
CapEx % of Revenue2.71%2.9%7.02%4.61%5.31%21.19%4.79%3.68%2.87%
Acquisitions0000000-50K-4.37M
Investments---------
Other Investing96K-3.96M-1.48M-1.65M-434K-525K-16.64M-9.45M-2.66M
Cash from Financing42.99M81.53M22.79M64.67M4.05M100.25M86.23M125.89M40.43M
Debt Issued (Net)22.97M-311K24.51M-277K-175K96.39M024.47M33.48M
Equity Issued (Net)-4.51M0063.85M4.58M3.87M84.54M99.48M7.59M
Dividends Paid000000000
Share Repurchases-4.51M00000000
Other Financing24.53M81.84M-1.72M1.09M-356K-4K1.69M1.94M-637K
Net Change in Cash
10.38M▲ 0%
41.77M▲ 302.3%
-14.98M▼ 135.9%
46.87M▲ 412.8%
-31.11M▼ 166.4%
12.94M▲ 141.6%
-26.32M▼ 303.4%
50.31M▲ 291.2%
-14.78M▼ 129.4%
Free Cash Flow
-32.91M▲ 0%
-35.66M▼ 8.3%
-36.98M▼ 3.7%
-16.42M▲ 55.6%
-34.26M▼ 108.7%
-86.43M▼ 152.3%
-113.06M▼ 30.8%
-74.08M▲ 34.5%
-56.94M▲ 23.1%
FCF Margin %-94.9%-58.26%-41.29%-19.39%-27.04%-53.45%-68.46%-44.62%-26.98%
FCF Growth %-32.6%-8.34%-3.72%55.61%-108.69%-152.28%-30.81%34.48%23.14%
FCF per Share-1.78-2.06-1.80-0.70-1.43-3.53-4.42-2.63-1.92
FCF Conversion (FCF/Net Income)0.92x1.61x0.79x0.33x0.67x0.69x1.13x0.69x1.00x
Interest Paid2.86M5.38M5.95M6.96M6.93M5.36M5.69M9.81M0
Taxes Paid147K136K649K316K652K2.13M2.17M1.74M0

ESTA Key Ratios

Establishment Labs Holdings Inc. (ESTA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)---65.45%-69.94%-66.54%-65.46%-353.48%-1537.75%-236.67%-133.25%
Return on Invested Capital (ROIC)-105.69%-154.14%-75.55%-51.84%-44.86%-39.9%-38.05%-35.42%-20.91%-14.61%
Gross Margin50.99%51.04%59.01%61.25%62%67.42%65.92%64.78%65.97%69.32%
Net Margin-111.91%-100.62%-34.47%-42.59%-45.02%-32.47%-46.51%-47.53%-50.95%-24.19%
Debt / Equity--0.32x1.22x0.70x1.07x-10.45x4.24x11.23x
Interest Coverage-5.45x-2.34x-1.37x-3.31x-3.06x-3.38x-5.19x-4.11x-3.06x-1.30x
FCF Conversion0.64x0.92x1.61x0.79x0.33x0.67x0.69x1.13x0.69x1.00x
Revenue Growth-75.15%76.49%46.33%-5.46%49.61%27.64%2.13%0.53%27.14%

ESTA SEC Filings & Documents

Establishment Labs Holdings Inc. (ESTA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Apr 30, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Mar 4, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 7, 2025·SEC

FY 2025

May 9, 2025·SEC

ESTA Frequently Asked Questions

Establishment Labs Holdings Inc. (ESTA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Establishment Labs Holdings Inc. (ESTA) reported $211.1M in revenue for fiscal year 2025. This represents a 966% increase from $19.8M in 2016.

Establishment Labs Holdings Inc. (ESTA) grew revenue by 27.1% over the past year. This is strong growth.

Establishment Labs Holdings Inc. (ESTA) reported a net loss of $51.1M for fiscal year 2025.

Dividend & Returns

Establishment Labs Holdings Inc. (ESTA) has a return on equity (ROE) of -133.3%. Negative ROE indicates the company is unprofitable.

Establishment Labs Holdings Inc. (ESTA) had negative free cash flow of $57.4M in fiscal year 2025, likely due to heavy capital investments.

Explore More ESTA

Establishment Labs Holdings Inc. (ESTA) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.